Access and affordability SHARx focuses on providing affordable access to high-cost prescription medications for uninsured and underinsured populations, presenting an opportunity to position supplier partnerships and cost-sharing programs with health plans and employers.

Strategic partnerships Recent collaboration with Mark Cuban Cost Plus Drug Company signals a track record of leveraging global supply networks to flatten costs; scale business development by targeting employer plan sponsors and managed care organizations seeking waste-to-benefit optimization.

Employer plan focus Revenue growth likely tied to employer benefits and plan sponsorship; target RFPs and benefits managers who aim to reduce prescription waste and premium volatility while expanding access to affordable meds.

Technology enablement Tech stack includes QuickBooks Online, Databricks, GitHub, WooCommerce, WordPress, KnowBe4, Slack, and analytics tooling; selling points include data-driven pricing, streamlined procurement, and secure workforce training for compliance.

Leadership and credibility New CEO appointment and a growth trajectory with mid-market revenue in the lower tens of millions; leverage leadership change and founder-CEO background to build trust with potential customers and partners seeking stability and vision.